Market Surveillance of Industrial Pharmacy

The Indian pharmaceutical industry, the most respected amongst the emerging nations, is one of the most sought after sectors from a global collaboration point of view. The Indian pharma sector offers a lot to be optimistic about. The sector which was only $ six billion in 2005 has zoomed to $18 billion market in 2012, clocking a CAGR of 17 per cent. The sector is expected to grow to $45 billion by 2020. Even in the most pessimistic scenario, the sector is expected to be the sixth largest in the world in terms of absolute size by 2020. The sector stands to benefit from various domestication and international driving factors. Exports continue to make a significant contribution to the industry economic growth story. Apart from the developed markets, Indian pharma companies have established a strong presence in other fast growing semi-regulated markets like Russia, South Africa and Latin America. The share of pharma companies of Indian origin is close to 73 per cent of the Indian market while multinational companies hold the rest 27 per cent. This clearly indicates that the majority share of the Indian market is with domestication Pharmaceutical companies and equally distributed amongst both large and small scale pharmaceutical companies. Currently, India’s share of the US generic market is 24 per cent in terms of volume and 40 per cent of the new product approvals granted by the US FDA has been to Indian companies (YTD 2013). It has established a strong reputation in the global space for being a high quality supplier of affordable generics. The Indian pharm sector is at the threshold of aggressive economic growth. It is believed that the Indian pharma market will be amongst the top three global markets in terms of incremental growth by 2020.

The Indian pharmaceutical industry, the most respected amongst the emerging nations, is one of the most sought after sectors from a global collaboration point of view. The Indian Pharma sector offers a lot to be optimistic about. The sector which was only $ six billion in 2005 has zoomed to $18 billion market in 2012, clocking a CAGR of 17 per cent. 

  • Present market scenario of industrial pharmacy
  • Future market scenario of industrial pharmacy
  • Sales and marketing of pharmaceutical products

Related Conference of Market Surveillance of Industrial Pharmacy

October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Market Surveillance of Industrial Pharmacy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in